Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23271)

• Formulation Name: Revefenacin 175 mcg/3 ml solution
• Company: Mylan Specialty L.P.

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Revefenacin	(DMMP5SI)	Chronic obstructive pulmonary disease	CA22	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Kyselina citronova	(E00014)	311	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Sodium citrate anhydrous	(E00102)	6224	Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Water	(E00035)	962	Solvent